Sian writes about emerging start-up companies and new research from academia. She is especially interested in the pet health space, as well as the introduction of digital technology for both companion animals and livestock. She also has an interest in increasing Animal Pharm's equine coverage, as she owns horses herself.
In addition to covering animal health news and conducting interviews with worldwide companies, Sian also works on the evolving Animal Pharm Product Approvals Index.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Sian Lazell
Pet cancer therapy specialist VetDC has said findings from a new study support the efficacy of its Tanovea-CA1 canine lymphoma treatment.
The European Medicines Agency (EMA) has found sales of antibiotics for animal use decreased by 13% in Europe between 2011 and 2015.
Pet health specialist Aratana Therapeutics is making its Entyce appetite stimulant for dogs available to US veterinarians.
Malaysian company BioValence recently won the Innovation Award at the Aquaculture Innovation Summit 2017 in London for its RetroMAD1 antiviral protein. But what else has the company got planned for other candidates in its pipeline? Animal Pharm analyst Sian Lazell spoke to the firm to find out more.
In an effort to drive its business in Europe, Belgian feed additive specialist Nutriad has opened a new office in Warsaw, Poland.
AnimalhealthEurope (formerly IFAH-Europe) has unveiled its new name and branding at a gala dinner held in Brussels to celebrate its 30th anniversary.